PQE Group eagerly anticipates participating in the 2024 PDA India Chapter Annual Meeting in Hyderabad from March 11-15, focusing on critical issues in the pharmaceutical and medical device sectors.
The conference will delve into topics such as environmental monitoring, aseptic processing, cleaning validation, cross-contamination, and compliance strategies within these industries. Regulatory insights and expert opinions on technologies, data integrity, and quality enhancement will be shared.
The inaugural day will witness opening remarks from distinguished figures including Dr. Sarah McMullen from the US FDA India Office, Alonza Cruse, Dr. Anil Sawant from Merck Sharpe & Dohme, USA, and Dr. Carmelo Rosa from CDER/OMQ/US FDA. Sessions on Quality Culture will be highlighted, led by notable speakers including Dr. G.K. Raju, Stephen Tyrpak, and Dr. Deva Puranam.
The “Back to Basics” workshop on March 14-15, organized by US FDA and industry experts, will delve into essential regulations and guidelines. Stephen Tyrpak will lead discussions on Quality Culture, risk management, and visual inspections with case studies and demonstrations. Various sessions led by FDA and EDQM regulators, along with industry experts, will enrich the conference.
Mahesh Jagtap, PQE India local partner, expressed enthusiasm, stating, “We’re thrilled to participate and support this significant event, crucial for the pharmaceutical and medical device industries in India. Since PQE Group’s establishment in India in 2019, we’ve grown to over 110 compliance professionals in the region. We eagerly anticipate a productive and educational week in Hyderabad, looking forward to reconnecting with peers and forging new partnerships at booth #7.”
